Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib)

MLA

Christopher B. Little, et al. “Modulation of Endochondral Ossification by MEK Inhibitors PD0325901 and AZD6244 (Selumetinib).” Bone, vol. 59, Feb. 2014, pp. 151–61. EBSCOhost, https://doi.org/10.1016/j.bone.2013.11.013.

APA

Christopher B. Little, Aaron Schindeler, David G. Little, Nikita Deo, Kathy Mikulec, Michelle M. McDonald, Mille Kolind, Miriam T. Jackson, & Jad El-Hoss. (2014). Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib). Bone, 59, 151–161. https://doi.org/10.1016/j.bone.2013.11.013

Chicago

Christopher B. Little, Aaron Schindeler, David G. Little, Nikita Deo, Kathy Mikulec, Michelle M. McDonald, Mille Kolind, Miriam T. Jackson, and Jad El-Hoss. 2014. “Modulation of Endochondral Ossification by MEK Inhibitors PD0325901 and AZD6244 (Selumetinib).” Bone 59 (February): 151–61. doi:10.1016/j.bone.2013.11.013.